We are delighted with the news that Paul Edwards MBE, our Managing Partner & Board Member, has been appointed Chair of OBN (UK) Ltd! Paul has played a pivotal role in our company since 2005 and is deeply connected to both scientific innovation and corporate transformation within our industry.
Specialising in international, senior level and board appointments across the life science, pharmaceutical, generics and medical device sectors, Paul has a track record of executive roles within a succession of innovative companies.
A graduate chemist with over 40 years in the industry, Paul has led many successful enterprises, both commercially and scientifically. His successes include preparing an exit strategy and final valuation at £230m for BioProducts Laboratory and working on cancer precision therapies as board advisor and interim CEO of NanoMab Technology Ltd.
“It’s a real privilege to be appointed as the new Chair of OBN (UK) Ltd. My association with the organisation goes back many years via the relationship between SCi Partners and OBN, where our membership and sponsorship activities have helped us to play a pivotal role in supporting the UK Life Sciences sector,” comments Paul.
Congratulations Paul! We know that you will deliver great value and expertise in your new role.
